Skip to main content

The Pistoia Alliance appoints advisory board to increase industry collaboration

The Pistoia Alliance, a global, not-for-profit alliance that works to lower barriers to innovation in life sciences research and development, has appointed an advisory board to guide its strategy. Providing insight and expertise from across life science research, the board consists of 12 senior individuals spread throughout Europe and the US.

Members are drawn from leadership positions in a variety of global life science, pharmaceutical and technology businesses; along with governmental and public bodies, including NICE and the NHS. The board will meet for the first time in London in March 2017.

‘Our new advisory board members bring many decades of invaluable experience from across the life sciences industry. From payers and providers to regulators and R&D heads – these knowledgeable individuals are perfectly placed to help develop our future strategy,’ commented Steve Arlington, president of The Pistoia Alliance. ‘Their insights into the key challenges, threats, and opportunities to the life sciences industry, will be crucial in helping our member companies direct their resources and keep on top of emerging trends.’

The new advisory board underlines its commitment to ensuring that members – which range from single individuals to global enterprises – continue to benefit from projects, events, and collaborations on key industry issues. Moreover, the Pistoia Alliance members and the newly appointed board will also have the chance to be exposed to new technologies and innovations that will generate significant value for the worldwide life sciences R&D community.

The Pistoia Alliance is a global, not-for-profit members’ organisation made up of life science companies, technology and service providers, publishers, and academic groups. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots.


Read more about:

Laboratory informatics, Business

Media Partners